Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia

Catheterization and Cardiovascular Diagnosis

Volumn 45, Issue 3, 1998, Pages 318-322

  Paulette Hale, L ^a   Smith, Karen ^a   Braden, Gregory A ^a   Owen, John ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Heparinoids; Thrombocytopenia

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; DANAPAROID; DRUG ANTIBODY; HEPARIN; HEPARINOID;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; ATHERECTOMY; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; THROMBOCYTOPENIA; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ATHERECTOMY, CORONARY; BLOOD COAGULATION; CHONDROITIN SULFATES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DERMATAN SULFATE; HEPARIN; HEPARINOIDS; HEPARITIN SULFATE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; THROMBOCYTOPENIA;

EID: 0345698680     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199811)45:3<318::AID-CCD23>3.0.CO;2-2     Document Type: Article

References (15)

1. Chong BH, Magnani HN: Orgaran in heparin-induced thrombocytopenia. Haemostasis 22:85-91, 1992.
2. Dryjski M, Dryjski H: Heparin induced thrombocytopenia. Eur J Vasc Endovasc Surg 11:260-269, 1996.
3. Stiekema JCJ, Wijnand HP, Van Dinther TG, Moelker HCT, Dawes J, Vinchenzo A, Toeberich H: Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers. Br J Clin Pharmacol 27:39-48, 1989.
4. Magnani HN: Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 70:554-561, 1993.
5. Weitz JI: Low-molecular-weight heparins. N Engl J Med 337:688-698, 1997.
6. Wilhelm MJ, Schmid C, Kececioglu D, Möllhoff T, Ostermann H, Scheld HH: Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172. Ann Thorac Surg 61:920-924, 1996.
7. Muhm M, Claeys L, Huk I, Koppensteiner R, Kyrie PA, Minar E, Stumpflen A, Ehringer H, Polterauer P: Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan). Wien Klin Wochenschr 109:128-131, 1997.
8. Ellis SG, Roubin GS, King SB, Douglas JS Jr, Weintraub WS, Thomas RG, Cox WR: Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77:372-379, 1988.
9. Harrington RA, Kleiman NS, Kottke-Marchant K, Lincoff AM, Tcheng JE, Sigmon KN, Joseph D, Rios G, Trainor K, Rose D, Greenberg CS, Kitt MM, Topol EJ, Califf RM: Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention. Am J Cardiol 76:1222-1227, 1995.
10. EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956-961, 1994.
11. EPILOG Investigators: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336:1689-1696, 1997.
12. Braden GA, Applegate RJ, Young TM, Love WW, Sane DC: Abciximab decreases both the incidence and magnitude of creatine kinase elevation during rotational atherectomy. J Am Coll Cardiol 29:499, 1997.
13. Gottlieb A, Tabares AH, Levy P, Sprung J, Kottke-Marchant K, Schoenwald PK: Use of low molecular weight heparin in patients with heparin-induced thrombocytopenia undergoing carotid endarterectomy. Anesthesiology 85:678-681, 1996.
14. Altés A, Martino R, Gari M, Cámara ML, Garín R, Casas JI, Fontcuberta J: Heparin-induced thrombocytopenia and heart operation: Management with tedelparin. Ann Thorac Surg 59:508-509, 1995.
15. Bradbrook ID, Magnani HN, Moelker HCT, Morrison PJ, Robinson J, Rogers HJ, Spector RG, Van Dinther T, Wijnand H: ORG 10172: A low molecular weight heparinoid anticoagulant with a long half-life in man. Br J Clin Pharmacol 23:667-675, 1987.